NCBP2 and colorectal carcinoma: Through pseudo-time analysis, we identified genes such as NCBP2, EIF3D, and NUDT4 boost the occurrence and development of malignant tumor epithelial cells, providing guidance for identifying potential therapeutic targets for CRC.